PL364086A1 - Zastosowanie azytromycyny do wytwarzania leku do leczenia niezakaźnych chorób zapalnych - Google Patents

Zastosowanie azytromycyny do wytwarzania leku do leczenia niezakaźnych chorób zapalnych

Info

Publication number
PL364086A1
PL364086A1 PL02364086A PL36408602A PL364086A1 PL 364086 A1 PL364086 A1 PL 364086A1 PL 02364086 A PL02364086 A PL 02364086A PL 36408602 A PL36408602 A PL 36408602A PL 364086 A1 PL364086 A1 PL 364086A1
Authority
PL
Poland
Prior art keywords
azithromycin
medicament
manufacture
treatment
inflammatory diseases
Prior art date
Application number
PL02364086A
Other languages
English (en)
Inventor
Ognjen Culic
Michael Parnham
Vesna Erakovic
Original Assignee
Pliva D.D.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pliva D.D. filed Critical Pliva D.D.
Publication of PL364086A1 publication Critical patent/PL364086A1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL02364086A 2001-04-27 2002-04-10 Zastosowanie azytromycyny do wytwarzania leku do leczenia niezakaźnych chorób zapalnych PL364086A1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HR20010301A HRP20010301A2 (en) 2001-04-27 2001-04-27 New therapeutic indication for azithromycin in the treatment of non-infective inflammatory diseases
PCT/EP2002/003984 WO2002087596A2 (en) 2001-04-27 2002-04-10 Use of azithromycin for the manufacture of a medicament for treatment of non-infective inflammatory diseases

Publications (1)

Publication Number Publication Date
PL364086A1 true PL364086A1 (pl) 2004-12-13

Family

ID=10947306

Family Applications (1)

Application Number Title Priority Date Filing Date
PL02364086A PL364086A1 (pl) 2001-04-27 2002-04-10 Zastosowanie azytromycyny do wytwarzania leku do leczenia niezakaźnych chorób zapalnych

Country Status (19)

Country Link
US (1) US20050054587A1 (pl)
EP (1) EP1392327A2 (pl)
JP (1) JP2004531539A (pl)
CN (1) CN1582158A (pl)
AR (1) AR034223A1 (pl)
BG (1) BG108286A (pl)
BR (1) BR0209276A (pl)
CA (1) CA2443381A1 (pl)
CZ (1) CZ20032932A3 (pl)
EA (1) EA200301187A1 (pl)
HR (1) HRP20010301A2 (pl)
HU (1) HUP0303988A2 (pl)
IL (1) IL158236A0 (pl)
MX (1) MXPA03009849A (pl)
PL (1) PL364086A1 (pl)
SK (1) SK13352003A3 (pl)
WO (1) WO2002087596A2 (pl)
YU (1) YU84503A (pl)
ZA (1) ZA200308933B (pl)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20020231A2 (en) 2002-03-18 2003-12-31 Pliva D D ISOSTRUCTURAL PSEUDOPOLYMORPHS OF 9-DEOXO-9a-AZA-9a-METHYL-9a-HOMOERYTHROMYCIN A
HRP20020614A2 (en) 2002-07-22 2004-06-30 PLIVA-ISTRAŽIVAČKI INSTITUT d.o.o. Rhombic pseudopolymorph of 9-deoxo-9a-aza-9a-methyl-9a-homoerythromycin a
GB0315671D0 (en) 2003-07-04 2003-08-13 Chelsea And Westminster Nhs Tr Improvements in or relating to organic compounds
JP2007516951A (ja) * 2003-12-30 2007-06-28 アステラス製薬株式会社 気道閉塞症の治療または予防のためのマクロライドの使用
WO2006115494A1 (en) * 2005-04-26 2006-11-02 American Pharmaceutical Partners, Inc. Lyophilized azithromycin formulation
US7468428B2 (en) 2004-03-17 2008-12-23 App Pharmaceuticals, Llc Lyophilized azithromycin formulation
KR101130252B1 (ko) * 2004-07-02 2012-03-26 와카모토 세이야꾸 가부시끼가이샤 아지스로마이신 함유 수성 의약 조성물 및 그 조제 방법
US20080200403A1 (en) * 2005-01-14 2008-08-21 Glaxosmithkline 9A-Carbamoyl and Thiocarbamoyl Azalides with Anti-Inflammatory Activity
US20060293261A1 (en) * 2005-06-24 2006-12-28 Taisho Pharmaceutical Co., Ltd. Clarithromycin or a salt thereof for the treatment or prevention of pulmonary disorders caused by the destruction of pulmonary alveoli
WO2007117661A2 (en) * 2006-04-03 2007-10-18 Teva Pharmaceutical Industries Ltd, Drug microparticles
US8124744B2 (en) 2006-05-01 2012-02-28 Taisho Pharmaceutical Co., Ltd. Macrolide derivatives
US7704959B2 (en) * 2006-10-03 2010-04-27 Dow Pharmaceutical Sciences Azithromycin for the treatment of nodular acne
WO2010006306A1 (en) * 2008-07-10 2010-01-14 Inspire Pharmaceuticals, Inc. Method of treating blepharitis
WO2010062787A1 (en) 2008-11-03 2010-06-03 Washington University Bioluminescence imaging of myeloperoxidase activity in vivo, methods, compositions and apparatuses therefor
WO2010085572A1 (en) * 2009-01-23 2010-07-29 Inspire Pharmaceuticals, Inc. Method of treating dry eye disease with azithromycin
PE20120220A1 (es) 2009-01-30 2012-04-04 Glaxo Group Ltd Macrolido anti-inflamatorio
WO2011116312A1 (en) * 2010-03-19 2011-09-22 Catabasis Pharmaceuticals, Inc. Fatty acid macrolide derivatives and their uses
US10500223B2 (en) * 2015-07-14 2019-12-10 Osaka University Therapeutic agent for myotonic dystrophy
CN113209084A (zh) * 2021-05-18 2021-08-06 南开大学 化合物cp0119在制备用于治疗炎性肠病的药物中的应用
US12521411B2 (en) 2024-05-06 2026-01-13 Baxter International Inc. Azithromycin premix formulation and product, methods of preparing same, and methods of using same

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI7910768A8 (en) * 1979-04-02 1996-06-30 Pliva Pharm & Chem Works Process for pripering 11-aza-4-0-cladinosyl-6-0-desosaminyl-15-ethyl- 7,13,14-trihydroxy-3,5,7,9,12,14-hexamethyl- oxacyclopentadecane-2-one and their derivatives
SI8110592A8 (en) * 1981-03-06 1996-06-30 Pliva Pharm & Chem Works Process for preparing of n-methyl-11-aza-10-deoxo-10-dihydroerythromycine a and derivatives thereof
YU45590A (sh) * 1990-03-07 1992-07-20 PLIVA FARMACEVTSKA, KEMIJSKA, PREHRAMBENA I KOZMETIČKA INDUSTRIJA s.p.o. Novi kompleksi odnosno helati antibiotika s dvovalentnim i/ili trovalentnim metalima i postupci za njihovo dobijanje
SI9011409A (en) * 1990-07-18 1995-10-31 Pliva Pharm & Chem Works O-methyl azitromycin derivates, methods and intermediates for their preparation and methods for preparation of pharmaceuticals products which comprise them
WO1995009601A1 (en) * 1993-10-01 1995-04-13 The Procter & Gamble Company Use of azithromycin for the treatment of adult periodontitis and topical compositions for this use
US5605889A (en) * 1994-04-29 1997-02-25 Pfizer Inc. Method of administering azithromycin
JP2977907B2 (ja) * 1994-05-06 1999-11-15 ファイザー・インコーポレーテッド アジスロマイシンの放出調節された剤形
GB9723669D0 (en) * 1997-11-07 1998-01-07 Univ Aberdeen Skin penetration enhancing components
DE19850445A1 (de) * 1998-11-02 2000-05-04 Falk Pharma Gmbh Arzneimittel zur topischen Behandlung entzündlicher Darmerkrankungen
DE60044515D1 (de) * 1999-06-29 2010-07-15 Sandoz Ag Azithromycinmonohydrat
IT1313610B1 (it) * 1999-08-09 2002-09-09 S I F I Societa Ind Farmaceuti Processo per la preparazione di formulazioni acquose per uso oftalmico
IL141438A0 (en) * 2000-02-23 2002-03-10 Pfizer Prod Inc Method of increasing the bioavailability and tissue penetration of azithromycin

Also Published As

Publication number Publication date
CZ20032932A3 (cs) 2004-08-18
YU84503A (sh) 2006-08-17
JP2004531539A (ja) 2004-10-14
AR034223A1 (es) 2004-02-04
SK13352003A3 (en) 2004-10-05
ZA200308933B (en) 2004-11-17
WO2002087596A2 (en) 2002-11-07
IL158236A0 (en) 2004-05-12
WO2002087596A3 (en) 2003-01-03
CN1582158A (zh) 2005-02-16
MXPA03009849A (es) 2004-05-24
US20050054587A1 (en) 2005-03-10
HRP20010301A2 (en) 2001-12-31
CA2443381A1 (en) 2002-11-07
HUP0303988A2 (hu) 2004-04-28
BG108286A (bg) 2004-09-30
EA200301187A1 (ru) 2004-04-29
EP1392327A2 (en) 2004-03-03
BR0209276A (pt) 2004-06-15

Similar Documents

Publication Publication Date Title
PL364086A1 (pl) Zastosowanie azytromycyny do wytwarzania leku do leczenia niezakaźnych chorób zapalnych
PL362711A1 (pl) Pochodne morfolinoacetamidu do leczenia chorób zapalnych
IL159344A0 (en) Quinuclidines-substituted-multicyclic-heteroaryls for the treatment of disease
IL196301A0 (en) Medicament for the treatment of hapatitis c
IL160884A0 (en) Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease
CY2014019I2 (el) Παραγωγα φαιναιθανολαμινης για θεραπεια ασθενειων του αναπνευστικου
NO20033594L (no) Fenetanolamin-derivater for behandling av luftveissykdommer
IL163725A0 (en) Administration of agents for the treatment of inflammation
NO20043000L (no) Et preparat for behandling av nevrocerebrovaskulaere sykdommer
IL161070A0 (en) Compositions for the treatment of infectious diseases
PT1487828E (pt) Derivados de morfolinil-ureia para utilização no tratamento de doenças inflamatórias
HUP0400024A3 (en) Combination for treatment of neoplastic diseases
GB0004531D0 (en) The treatment of respiratory diseases
PL1670482T5 (pl) Zastosowanie cyklezonidu w leczeniu chorób układu oddechowego
AU2002338303A1 (en) Therapeutic compositions for the treatment of a respiratory tract disease
AU2003303217A8 (en) Use of substituted 2,5-diamidoindoles for the treatment of urological diseases
PL373490A1 (pl) Zastosowanie agonistów beta-adrenoreceptorów do leczenia chorób neurodegeneratywnych
AU4453301A (en) Use of spirolaxin for the treatment of diseases associated with abnormal angiogenesis
GB0222282D0 (en) Therapeutic device for the treatment of symptons caused by diseases
NO20042166L (no) Kombinasjonsterapi for behandling av sykdom
GB0108892D0 (en) The treatment of respiratory diseases
AU2728301A (en) Combination therapy for the treatment of inflammatory and respiratory diseases
AU2002365654A8 (en) Treatment of diseases via the skin
EP1426060A4 (en) REMEDIES FOR ALLERGIC DISEASES
GB0118977D0 (en) New medical treatment

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)